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Abstract 
 
Background: The Definitive Endoderm (DE) differentiation using the undefined me-
dia and non-human feeders can cause contaminations in the generated cells for ther-
apeutic applications. Therefore, generating safer and more appropriate DE cells is 
needed. This study compared five different methods to establish an appropriate 
method for inducing an efficient DE differentiation from Human Induced Pluripotent 
Stem Cells (hiPSCs) on an appropriate feeder in a more defined medium. 
 
Methods: Human Induced Pluripotent Stem Cells (hiPSCs) were cultured on inacti-
vated feeders. Passaged hiPSCs, without feeder, were incubated for three days with 
Activin-A and different endodermal differentiation media including 1-FBS, 2-B27, 3-
ITS and albumin fraction-V, 4-B27 and ITS and 5-like the third medium. The feeder 
cells in the first four methods were Mouse Embryonic Fibroblasts (MEFs) and in the 
fifth method were human adult bone marrow Mesenchymal Stem Cells (hMSCs). DE 
markers FOXA2, SOX17 and CXCR4 and also pluripotency marker OCT4 were evalu-
ated using qRT-PCR, as well as FOXA2 by the immunocytochemistry. 
 
Results: QRT-PCR analysis showed that after three days, the expression levels of DE 
and pluripotency markers in the differentiated hiPSCs among all five groups did not 
have any significant differences. Similarly, the immunocytochemistry analysis demon-
strated that the differentiated hiPSCs expressed FOXA2, with no significant differ-
ences. 
 
Conclusion: Despite this similarity in the results, the third differentiation medium has 
more defined and cost effective components. Furthermore, hMSC, a human feeder, is 
safer than MEF. Therefore, the fifth method is preferable among other DE differentia-
tion methods and can serve as a fundamental method helping the development of 
regenerative medicine. 
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 Introduction 
 
The application of cell culture-derived products is 
evolving in medical treatment 1. If unlimited numbers 
of vital in vitro differentiated cells are obtained, the 
development of cell-based therapies and the study of 
the early stages of the drug discovery for the diseases 
will be improved 2. The ability of hiPSCs for self-
renewing and the potential to differentiate into three 
embryonic germ layers, i.e. ectoderm, mesoderm and 
endoderm, makes it possible to use them as an appro-
priate source of cells in regenerative medicine 3. Unlike 
many other stem cells, Embryonic Stem Cells (ESCs) 
and iPSCs are able to unlimitedly proliferate without  
 
 
 
 
 
losing potency. The advantage of using iPSCs is the 
source of autologous cells they supply 4. Thus, they are 
considered as an infinite source for the production of 
vital matured cells in vitro and might be used as a main 
component in the cell therapy 5.  
Stem cells, such as iPSCs, are usually maintained on 
a layer of feeder cells. Feeder layers have many advan-
tages for stem cells, such as maintaining their undiffer-
entiated situation and pluripotency. hiPSCs are usually 
maintained on inactivated Mouse Embryonic Fibro-
blasts (MEFs) as a feeder, but applying non-human 
feeder cells can produce biological contaminants such 
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as exogenous antigens, viruses and pathogens. To 
avoid these contaminations, diverse human cells, such 
as fibroblasts from neonatal foreskin, ESC-derived fi-
broblast-like cells, autologous fibroblasts, immortaliz-
ed human skin fibroblasts, and human Mesenchymal 
Stem Cells (hMSCs) were used as feeder layers to 
maintain ESCs, although their ability was different 
from each other 6-9. The feeder-free culture techniques 
for human ESCs have also been reported, but they have 
many problems such as chromosomal instabilities of 
human stem cells 8. HMSCs generate several necessary 
elements for stem cells, for instance TGF-beta. They 
have been extensively applied for clinical applications. 
HMSCs are a highly developed feeder for the stem cell 
cultures and could be derived from healthy adult do-
nors and proliferated multifold before applying as a 
feeder layer 5,10.  
Diverse serum and serum-free culture media for the 
induction of differentiation of stem cell-derived endo-
derm cells have been reported in previous studies 11,12. 
Classifying the animal cell culture media into subcate-
gories according to the rate of defined media, classified 
from low to high definition, gives us serum-containing 
medium, reduced-serum medium, serum-free medium, 
protein-free medium, chemically-defined medium and 
protein-free chemically-defined medium 1. Generating 
safer and more efficient cells using more appropriate 
culture media and feeder layers provides more ade-
quate cells for cell transplantation therapies. To the 
best of our knowledge, no study has been conducted on 
the comparison of different differentiation media and 
feeder layers in endodermal differentiation of hiPSCs. 
DE differentiation is the first important step to obtain 
endodermal organs, such as the liver and pancreas 13. 
Forkhead box A2 (FOXA2), SRY-box containing gene 
17 (SOX17) and C-X-C chemokine receptor type 4 
(CXCR4) are DE marker genes 14. Octamer-binding 
Transcription factor 4 (OCT4) is a pluripotency and 
stem cell specific marker 15. In this study, an attempt 
was made to focus on the comparison of endodermal 
differentiation from hiPSCs, on a novel hMSCs feeder 
and on a typically used MEFs feeder, in different se-
rum and serum-free endodermal differentiation media, 
regarding their efficiency and safety, and the estab-
lishment of an appropriate method to generate adequate 
cells for cell transplantation therapies. 
 
 Materials and Methods 
 
Feeder cell culture 
MEFs and human adult bone marrow-derived MSCs 
were used as feeder layers in this study. For producing 
MEFs, pregnant female mice were used. The mice 
were obtained from Stem Cells Technology Research 
Center (Tehran, Iran) and all animal experiments were 
performed under control and supervision of its ethical 
committee. On the 13th day of female mice pregnancy, 
MEFs were taken from their embryos. The dissecting 
of the embryos from the womb was done considering 
sterile conditions and afterwards they were washed 
with Phosphate-Buffered Saline (PBS). The red organs 
and embryos' heads were detached, and the rest of the 
tissue was chopped up and put in 0.25% trypsin at 
37C for 20 min to be digested. The cell suspensions 
were cultured in Dulbecco's Modified Eagle's Medium 
(DMEM, Gibco, USA) supplemented with 10% (v/v) 
fetal bovine serum (FBS, Gibco, USA) and 1% penicil-
lin/streptomycin and incubated in a standard gas at-
mosphere with 95% humidity and 5% CO2 at 37C. 
The cells (Passage 3) were moved into 6-well cell cul-
ture plates. When they reached 90% confluency, they 
were mitotically inactivated by mitomycin-C (10 µg/ 
ml, Santa Cruz Biotechnology, USA). Human adult 
bone marrow-derived MSCs (Passage 5) were obtained 
from Stem Cells Technology Research Center (Tehran, 
Iran), under control and supervision of its ethical 
committee. They were plated and inactivated under the 
same conditions like MEFs 7,16,17. 
 
hiPSC culture 
hiPSCs were obtained from Stem Cells Technology 
Research Center (Tehran, Iran). The number of passag-
es used, ranged from 8 to 14 7. They were cultured on a 
layer of inactivated feeder cells in 6-well cell culture 
plates in DMEM/F12 with 10% knockout serum re-
placement, 10% FBS stem cell qualified replacement, 
1% glutamax (all from Gibco, USA), 1% non-essential 
amino acids (PAA, Austria), 10 ng/ml basic fibroblast 
growth factor (Peprotech, USA) and 1% penicillin/ 
streptomycin in a standard gas atmosphere with 95% 
humidity and 5% CO2 at 37°C 18.  
 
Endodermal differentiation of the hiPSCs  
After hiPSC colonies grew up and reached about 
70% confluency, hiPSCs were passaged by collagenase 
type IV (Gibco, USA) treatment and transferred into 
0.1% gelatin-coated 6-well cell culture plates at a den-
sity of 15×105 cells per well, without feeder cells. They 
were differentiated into the endoderm cells directly 
without Embryoid Bodies (EBs) formation, using five 
protocols coming in the next paragraph. hiPSCs cul-
tured on the MEFs feeder were differentiated using the 
following four protocols and hiPSCs cultured on the 
hMSCs feeder were differentiated using only protocol 
5. These five protocols include: 
 
1- hiPSCs were incubated for 3 days with RPMI-1640 
medium (Gibco, USA) containing 100 ng/ml Activin A 
(R&D, USA) and FBS (Gibco, USA). The concentra-
tion of FBS was 0% on the first day, 0.1% on the se-
cond day and 1.0% on the third day 2,11.   
2- hiPSCs were incubated for 3 days with RPMI-1640 
medium (Gibco, USA) containing 100 ng/ml Activin A 
(R&D, USA) and 1.0% B27 (Gibco, USA) 12,19.  
3- hiPSCs were incubated for 3 days with RPMI-1640 
medium (Gibco, USA) containing 100 ng/ml Activin A 
(R&D, USA), 0.5 mg/ml albumin fraction V (Sigma-
Aldrich, USA) and insulin-transferrin-selenite (ITS, 
Gibco, USA). The concentration of ITS was 0% on the 
4 
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first day, 0.1% on the second day and 1.0% on the third 
day 18,20. 
4- hiPSCs were incubated for 3 days with RPMI-1640 
medium (Gibco, USA) containing 100 ng/ml Activin A 
(R&D, USA), 1.0% B27 (Gibco, USA) and insulin- 
transferrin-selenite (ITS, Gibco, USA). The concentra-
tion of ITS was 0% on the first day, 0.1% on the se-
cond day, and 1.0% on the third day 5.  
5- The same protocol as protocol 3 was used, but 
hiPSC colonies grew up on the hMSCs feeder instead 
of the MEFs feeder. 
 
Evaluation of differentiated cells 
 
Immunocytochemistry: The cells were washed with 
PBS, fixed in 4% paraformaldehyde (Sigma-Aldrich, 
USA) in PBS at 4°C for 20 min and then at Room 
Temperature (RT) for 5 min. They were washed with 
PBS twice and then incubated with 0.2% Triton X-100 
at RT for 30 min. After washing with PBS, the cells 
were blocked with 10% goat serum (Gibco, USA) at 
RT for 30 min and then removed. They were incubated 
with a primary antibody at 4°C overnight. On the next 
day, the cells were washed with PBS 3 times. After 
that, they were incubated with a secondary antibody at 
RT for 1 hr and then washed with PBS 3 times. The 
nuclei of cells were stained with DAPI (1 µg/ml) for  
30 s at RT, and then washed with PBS. The cells were 
examined using a fluorescent microscope (Nikon, Ja-
pan). The primary antibody was rabbit anti-FOXA2 
antibody (Santa Cruz Biotechnology, USA) diluted at 
1:200. The secondary antibody was goat anti-rabbit 
IgG-FITC antibody (Santa Cruz Biotechnology, USA), 
diluted at 1:200. 
 
Quantitative real-time PCR (qRT-PCR) 
Total RNA from the undifferentiated and differenti-
ated hiPSCs was extracted using Trizol reagent (Gibco, 
USA). Next, 2 µg of total RNA was used with cDNA 
synthesis kit (Fermentas, USA) and random hexamer  
 
primers, according to the manufacturer's protocol. 
QRT-PCR was done by using SYBR Premix ExTaq kit  
 
(Takara, Japan) and a Rotor Gene 6000 real-time PCR  
 
system (Corbett, Australia). Data was normalized to a 
housekeeping gene (Beta2M) and analyzed by the 
comparative CT method. The primer sequences are 
shown in the table 1. They were obtained from Stem 
Cells Technology Research Center (Tehran, Iran) 5.  
The PCR reaction was composed of 6.5 µl of SYBR  
Green PCR Master Mix, 0.5 µl 10 µM of forward pri- 
mer, 0.5 µl 10 µM of reverse primer, 1 µl of template 
cDNA, and 4.5 µl of water in a total volume of 13 µl. 
The reaction was done at 95°C for 2 min, followed by 
40 cycles of 95°C for 5 s and 60°C for 45 s. 
 
Statistical analysis 
All experiments were repeated in triplicate. The in-
formation was represented as mean±standard deviation 
(SD). The statistical analyses were done using One-
way ANOVA. The p<0.05 (marked*) were considered 
statistically significant. 
 
Results 
 
MEFs and HMSCs displayed spindle-shaped and fi-
broblastic morphology (Figures 1A and 1B). hiPSCs 
colonies were cultured on a layer of mitotically inacti-
vated MEFs or hMSCs as a feeder. hiPSCs had mor-
phologically large nuclei and little cytoplasm. Colonies 
of hiPSCs were flat and tightly packed (Figures 1C and 
1D). For the endodermal differentiation, hiPSCs were 
passaged and transferred into the cell culture plates 
without feeder cells. hiPSCs cultured on MEFs feeder 
were differentiated using protocols 1 to 4 and those on 
hMSCs feeder were differentiated using protocol 5 
which is like protocol 3 in used materials (Figures 1E 
and 1F). After three days of growth factor treatment, 
Table 1. Primer sequences and conditions used in qRT-PCR analysis 
 
Gene  Sequences (forward and reverse)  Tm (°C)  Product size (bp)
OCT4  5´-TTC GCA AGC CCT CAT TTC AC-3´  60  114 
5´-CCA TCA CCT CCA CCA CCT G-3´ 
FOXA2 
5´-AGC GAG TTA AAG TAT GCT GG-3´ 
58 93 
5´-GTA GCT GCT CCA GTC GGA-3´ 
SOX17 
5´-CAA GAT GCT GGG CAA GTC-3´ 
60 93 
5´-TGG TCC TGC ATG TGC TG-3´ 
CXCR4 
5´-CGC CAC CAA CAG TCA GAG-3´ 
58 176 
5´-AAC ACA ACC ACC CAC AAG TC-3´ 
Beta2M 
5´-ATG CCT GCC GTG TGA AC-3´ 
56 91 
5´-ATC TTC AAA CCT CCA TGA TG-3´ 
 
Figure 1. Phase contrast microscopy images of A) MEFs (Scale bar= 
200 µm); B) hMSCs (Scale bar=100 µm); C) hiPSC colones on 
MEFs feeder (Scale bar=200 µm); D) hiPSC colonies on hMSCs 
feeder (Scale bar=200 µm); E) differentiated hiPSCs using protocol 3 
and MEFs feeder (Scale bar=800 µm); F) differentiated hiPSCs using 
protocol 5 and hMSCs feeder (Scale bar=800 µm). 
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the mRNA expression levels of DE markers FOXA2, 
SOX17 and CXCR4 and also the pluripotency marker 
OCT4 were evaluated in the differentiated cells using 
qRT-PCR to determine the in vitro differentiation effi-
ciency. Also, DE and pluripotency markers in the un-
differentiated hiPSCs were evaluated as well. QRT-
PCR analysis showed that the undifferentiated hiPSCs 
expressed OCT4 in a high level, while the expression 
levels of FOXA2, SOX17 and CXCR4 were remarka-
bly low. After 3 days of growth factor treatment, the 
expression levels of DE markers were increased signif-
icantly (p<0.05), whereas, the expression level of 
OCT4 was reduced significantly (p<0.05) in the differ-
entiated cells using different DE differentiation media 
and feeder layers (Figure 2). These qRT-PCR results 
showed that hiPSCs could be differentiated into DE 
cells efficiently in vitro. These data also demonstrated 
that mRNA expression levels of DE and pluripotency 
markers did not have any significant differences in the 
generated cells using listed DE differentiation media 
and two feeder layers, MEFs and hMSCs. The expres-
sion level of FOXA2 was increased 39.47±0.84 times 
in the differentiated hiPSCs using protocol 1(P1), com-
pared to the undifferentiated hiPSCs, 36.12±2.01 using 
P2, 37.34±2.03 using P3, 35.12±0.72 using P4 and 
39.41±0.83 using P5 (Figure 2B). The expression level 
of other DE markers, SOX17 and CXCR4, and also the 
pluripotency marker OCT4, in the differentiated hiPSCs 
compared to the undifferentiated hiPSCs, are present in 
figure 2.  
Also, DE marker FOXA2 expression was evaluated 
at the protein level using immunocytochemical analy-
sis. The number of positively stained cells with DE 
marker FOXA2 was determined and it was divided into 
the total number of the cells, determined by counting 
the number of their stained nuclei. Based on this num-
ber, the percentage of differentiated cells was obtained 
21. After treatment with different endodermal differen-
tiation media for three days, immunocytochemical an-
alysis showed that 77.67-82.33% of the cells generated 
using five methods expressed DE marker FOXA2 (Fig-
ures 3A and 3B). These results demonstrated that the 
generated cells expressed DE marker FOXA2 in a high 
level using different endodermal differentiation media 
and feeder layers and no significant differences in the 
percentages of the differentiated cells of the five groups 
were detected in the positive DE marker FOXA2.  
 
Discussion 
 
Choosing a suitable endodermal differentiation me-
dium and feeder layer is an important step for obtain-
ing safe and efficient endoderm cells, especially for 
their use in the differentiation into the cells used for 
cell replacement therapy. In this report, DE and 
pluripotency markers of the cells differentiated from 
hiPSCs in three days using four different endodermal 
differentiation media and two different feeders were 
compared. hiPSCs were cultured on hMSCs or MEFs 
feeder. The hiPSCs colonies cultured on hMSCs feeder 
were more typical and with more defined borders than 
colonies on MEFs feeder (Figure 1). After three days 
Figure 2. QRT-PCR analysis of DE and pluripotency markers. Be-
ta2M was considered as the housekeeping gene. The values of undif-
ferentiated hiPSCs were set at 1. Experimental values were expressed 
as mean±standard deviation (SD); * p<0.05, hiPSC-U: undifferentiat-
ed hiPSCs, hiPSC-D: differentiated hiPSCs, P1: Protocol 1, P2: Pro-
tocol 2, P3: Protocol 3, P4: Protocol 4, P5: Protocol 5. 
B 
Protocol FOXA2-positive cells 
1 77.67±6.11% 
2 80.54±3.42% 
3 79.34±5.03% 
4 82.33±3.51% 
5 80.82±4.16% 
Figure 3. A: Immunocytochemistry staining of expression of DE 
marker FOXA2 in differentiated hiPSCs. After treatment with dif-
ferent endodermal differentiation media for three days, the differen-
tiated hiPSCs were stained with rabbit anti-FOXA2 antibody and 
goat anti-rabbit IgG-FITC antibody. Nuclei were stained with DAPI. 
Scale bar=100 µm; B: The percentage of the cells expressing 
FOXA2 on the third day of the differentiation. Data represent the 
proportion of FOXA2-positive cells to the total cells in percentage. 
No significant differences in the percentages of the FOXA2-positive 
cells of five groups were detected. Data show the mean±standard 
deviation (SD) of three independent experiments. 
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of growth factors treatment, qRT-PCR results showed 
that in the differentiated cells using different differenti-
ation media and feeder layers, the expression levels of 
DE markers FOXA2, SOX17 and CXCR4 were in-
creased significantly, whereas, the expression level of 
OCT4 was reduced significantly (Figure 2). Immuno-
cytochemical analysis showed that after three days, 
77.67-82.33% of the generated cells using five meth-
ods expressed FOXA2 (Figure 3). These data were 
consistent with the existing reports in the endodermal 
differentiation of hiPSCs 5,12,18,22. In our study, these 
qRT-PCR and immunocytochemical results showed 
that hiPSCs were differentiated into DE cells efficient-
ly using different differentiation media and feeder lay-
ers. These results also demonstrated that the cells dif-
ferentiated from hiPSCs, using different listed differen-
tiation media and feeder layers, were similar and show-
ed no significant differences. Therefore, they were dif-
ferentiated with similar efficiencies. However, the ma-
terials used in these four differentiation media were not 
similar in terms of the level of defined media and also 
the sources of their feeder cells were not identical. By 
using hMSCs feeder, which is a human feeder, biologi-
cal contaminations of non-human feeders can be pre-
vented.  
In previous reports, the differentiation was done 
through EBs formation that imitates embryo develop-
ment 22 or without EBs formation 4. Although EBs 
formation is helpful for an efficient differentiation of 
stem cells, the derived cells are a mixture belonging to 
three germ layers; consequently, it is better to differen-
tiate stem cells into the endoderm cells directly without 
EBs formation by culturing a monolayer of stem cells 
23. Therefore, in this report, hiPSCs were moved into 
the cell culture plates straightly without EBs formation. 
In an existing study 5, it has been indicated that 
hiPSCs could be efficiently differentiated into the en-
doderm cells through EBs formation in the differentia-
tion media, including Activin A, ITS and B27 supple-
ments using hMSCs feeder. Furthermore, in the fifth 
method of this study, it was indicated that hiPSCs 
could be efficiently differentiated into the endoderm 
cells in a more defined medium without B27 supple-
ment, only using Activin A, ITS and albumin fraction 
V, without EBs formation, and using hMSCs feeder. 
Bovine Serum Albumin is also one of the ingredients 
of B27 supplement. Therefore, the differences of our 
fifth method with previously published methods 5 are 
the use of a non-EB formation method and also a more 
defined and cost effective medium with fewer compo-
nents.  
In other studies it has been indicated that hiPSCs 
and hESCs could be efficiently differentiated into the 
endoderm cells without EBs formation in the differen-
tiation media, including Activin A, ITS and albumin 
fraction V using MEFs feeder 18,20. Therefore, in com-
parison to previously published methods 18,20, in our 
fifth method of this study, it was shown that hiPSCs 
could be efficiently differentiated into the endoderm 
cells in the same medium, but by using hMSCs feeder. 
Similar to other existing reports 11,12, our data 
showed that Activin A can induce efficient endodermal 
differentiation in the serum-free and in serum contain-
ing media. Various concentrations of Activin will in-
duce different fates in cells. High dose of Activin in-
duces endoderm efficiently, while mesoderm is in-
duced at low and intermediate concentrations of Acti-
vin 24. The treatment with only Activin is not sufficient 
to induce the endoderm efficiently 25. Therefore, some 
supplements were used in our differentiation media 
beside a high concentration of Activin A. hiPSCs were 
differentiated into the endoderm cells efficiently using 
all the listed endodermal differentiation media. 
In the first differentiation medium, FBS was used in 
addition to Activin A 2,11. The application of the animal 
serum in culture media has some disadvantages. Serum 
is an ill-defined ambiguous supplement, containing un-
known and undesirable factors; it has different batch to 
batch compositions (both quantitatively and qualita-
tively). These can cause transferring a number of dif-
ferent undefined variables and contaminations to the 
cell culture and derived products. Therefore, it may 
hinder the therapeutic applications of the generated 
cells 20,26. 
In the second and fourth differentiation media, B27 
supplement was used in addition to Activin A 4,12. B27 
supplement is a serum-free supplement that contains 
twenty components. B27 contains five ingredients of 
animal/human origin, including Catalase, Superoxide 
Dismutase, Human Transferrin, Bovine Serum Albu-
min (BSA) and D-Galactose and additionally two com-
ponents in which animal/human-derived ingredients 
are used in the manufacturing process, including Hu-
man Recombinant Insulin and Progesterone 27. 
In the third differentiation medium, albumin fraction 
V and ITS supplement were used in addition to Activin 
A 18,20. Also, in the fourth differentiation media, both 
supplements, B27 and ITS 5, were used. ITS supple-
ment is a serum-free supplement which contains three 
components. It consists of one ingredient of animal/ 
human origin, which is Human Transferrin and also 
one component in which animal/human-derived ingre-
dients are used in its manufacturing process, which is 
Human Recombinant Insulin 28. 
Some contaminants like lipid contents of albumin 
are found in undefined animal-derived components 29. 
In case the cells which use these undefined animal-
derived components are applied for therapeutic use, 
they may cause problems 4. A troublesome matter of 
tissue regeneration, using in vitro differentiated cells, is 
contamination with the undefined factors 25. Lack of 
using animal-derived components has been increased 
due to the development of therapeutic applications for 
products derived from cell culture. This elimination 
helps to reduce the transfer of unwanted contamina-
tions 1. 
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B27 and ITS supplements are both serum-free and 
incompletely defined media, but ITS supplement has 
fewer animal-derived components; therefore, it has 
fewer disadvantages according to its animal-derived 
components 27-29. For example, according to previous 
reports 4, the repetition capacity of the process is de-
creased by using undefined factors because of its po-
tential variability whereas variability is reduced by 
using well-defined components, hence making it easier 
to carry out comparative studies. In addition, the con-
centration of ITS ingredients is written in its manual 28, 
while the concentration of B27 ingredients is not writ-
ten in its manual and it is confidential 27. This can lead 
to our inability to analyze the effects of different con-
centrations of B27 ingredients in the process when B27 
supplement is used in it.  It seems that the cost of the 
process can be decreased as well by using albumin 
fraction V and ITS instead of B27 or instead of B27 
and ITS both. Moreover, as the previous studies indi-
cate, using well-defined components makes the analy-
sis of molecular pathways, which regulate differentia-
tion, easier and more accurate 4; however, numerous 
undefined components may result in unwelcome ef-
fects 12. 
 
Conclusion 
 
Altogether, the fifth DE differentiation method, in-
cluding the combination of Activin A, albumin fraction 
V and ITS, and hMSCs feeder, appears to be a prefera-
ble DE differentiation method among other listed 
methods for inducing the differentiation of hiPSCs into 
DE cells. This is an efficient and safe method for direct 
induction of DE differentiation from hiPSCs. It can 
contribute as a fundamental method to assist the devel-
opment of cell transplantation therapies and regenera-
tive medicine. 
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